Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis

MLA

Toru Miyajima, et al. “Thiotepa-Based High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Neurolymphomatosis.” International Journal of Hematology, Jan. 2023. EBSCOhost, https://doi.org/10.1007/s12185-023-03544-8.

APA

Toru Miyajima, Reiki Ogasawara, Shihori Tsukamoto, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, Akio Mori, Makoto Saito, Masanobu Morioka, & Takeshi Kondo. (2023). Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis. International Journal of Hematology. https://doi.org/10.1007/s12185-023-03544-8

Chicago

Toru Miyajima, Reiki Ogasawara, Shihori Tsukamoto, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, Akio Mori, Makoto Saito, Masanobu Morioka, and Takeshi Kondo. 2023. “Thiotepa-Based High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Neurolymphomatosis.” International Journal of Hematology, January. doi:10.1007/s12185-023-03544-8.